Electrocardiographic correlates of microalbuminuria in adult Nigerians with essential hypertension

Cardiology Journal

Volumn 17, Issue 3, 2010, Pages 281-287

  Busari, Olusegun ^a   Opadijo, George ^b   Olarewaju, Timothy ^c   Omotoso, Abo ^d   Jimoh, Ahmed ^a  

^a FEDERAL MEDICAL CENTER   (Nigeria)

^b Ladoke Akintola University Teaching Hospital   (Nigeria)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

Electrocardiographic changes; Hypertension; Microalbuminuria; QTc

Indexed keywords

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; ECG ABNORMALITY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HEART REPOLARIZATION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE EXTRASYSTOLE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; NIGERIA; QT PROLONGATION; SCREENING; SUPRAVENTRICULAR PREMATURE BEAT; ALBUMINURIA; ARRHYTHMIAS, CARDIAC; BLACK PERSON; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPLICATION; ELECTROCARDIOGRAPHY; ETHNOLOGY; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALBUMINURIA; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NIGERIA; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77953335982     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Chobaman AU, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: JNC 7 report. JAMA 2003; 289: 2560-2572.
2. Akinkugbe OO. Current epidemiology of hypertension in Nigeria. Arch Ibadan Med, 2002; 1: 3-5.
3. Non-communicable diseases in Nigeria. Final Report of the National Survey. Federal Ministry of Health National Expert Committee on Non-communicable Diseases, 1997.
4. Kadiri S, Walker O, Salako BL, Akinkugbe OO. Blood pressure, hypertension and correlates in urbanized workers in Ibadan, Nigeria: A revisit. J Hum Hypertens, 1999; 13: 23-27.
5. Kahn S, Frishman WH, Weissman S. Left ventricular hypertrophy on electrocardiogram: prognostic implications for a 10-year cohort study of older subjects: a report from Bronx Longitudinal Aging Study. J Am Geriatric Soc, 1996; 44: 514-529.
6. th Ed. Mosby, St. Louis 1999.
7. th Ed. WB Saunders, Philadelphia 2001.
8. Parving J, Haywood JR, Toney GM, Jose PM. Increased urinary albumin excretion rate in benign hypertension. Lancet 1974; 1: 1190-1192.
9. Mogensen CE, Keane WF, Bernette PH et al. Prevention of diabetes renal disease with special reference to microalbuminuria. Lancet 1995; 346: 1080-1084.
10. Deckert T, Feldt-Rasmmussen RB, Borch-Johnsen JK et al. Albuminuria reflects widespread vascular damage. The steno hypothesis. Diabetologia, 1989; 32: 219-226.
11. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988; 2: 530-533.
12. Diercks GFH, van Boven AJ, Hillege HL et al. Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study. Eur Heart J, 2000; 21: 1922-1927.
13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
14. Garrow GS, Webster J. Quartelet index as a measure of fatness. Int J Obes, 1985; 147.
15. Kaplan NM. The deadly quartet: Upper body obesity, glucose intolerance, hyperlipidaemia and hypertension. Arch Int Med, 1989; 149-154.
16. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Int Med, 1997; 157: 2413-2446.
17. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens, 2003; 1983-1992.
18. Bazett HC. Analysis of the time relations of electrocardiograms. Heart, 1918; 7: 353-370.
19. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J, 1946; 37: 161-186.
20. Morris JS, Estes EH, Whalen RE, Thompson KH, McIntosh HD. P wave analysis in valvular heart disease. Circulation, 1994; 29: 242-252.
21. Araoye MA, Opadijo OG, Omotoso ABO. Appraisal of the electrocardiographic signs of left atrial enlargement. Nig Postgrad Med J, 2000; 6: 161-166.
22. Tiu SC, Lee SS, Cheng MW. Comparison of six commercial techniques in the measurement of microalbuminuria in diabetic patients. Diabetes Care, 1993; 16: 616-620.
23. Busari OA. Correlation between electrocardiographic left ventricular hypertrophy and microalbuminuria in newly diagnosed adult Nigerian hypertensive patients. Fellowship Dissertation of National Postgraduate Medical College of Nigeria, 2004.
24. Akinsola A, Balogun MO, Arogundade FA, Olatunde LO. Microalbuminuria and its clinical correlates in essential hypertension. Nig J Health Sci, 2002; 2: 25-29.
25. Dierks GFH, Hillege HL, van Boven AJ. Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes. J Am Coll Cardiol, 2002; 40: 1401--1407.
26. Wool J, Karad I, Thomas ME. Microalbuminuria and other cardiovascular risk factors in non-diabetic subjects. Int J Cardiol, 1992; 37: 345-350.
27. Rayner B, Becker P. The prevalence of MA and ECG LVH in hypertensive patients in private practices in South Africa. Cardiovasc J South Af, 2006; 17: 245-249.
28. de-la-Sierva A, Bragulat E, Sierra C et al. Microalbuminuria in essential hypertension: clinical and biochemical profile. Br J Biomed Sci, 2000; 57: 287-291.
29. Seiegl D, Cheitlia MD, Black D, Seeley D, Hearst M, Hulley SB. Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardio, 1990; 65: 742-747.
30. Salles G, Cardoso C, Nogueira AR, Bloch K, Muxfeldt E. Importance of the electrocardiographic strain pattern in patients with resistance hypertension. Hypertens, 2006; 48: 437-442.
31. Dell'omo G, Giorgi D, Di Bello V, Mariani M, Pedrinelli RJ. Blood pressure independent association of microalbuminuria and left ventricular hypertrophy in hypertensive men. J Intern Med, 2003; 254: 76-84.
32. Ichihara Y, Sugino M, Hatton R, Anno T, Mizuno Y, Yokoi M. Relation of electrocardiographic hypertrophy with and without T wave changes to systemic blood pressure, body mass, serum lipids and blood glucose in Japanese men. Am J Cardiol, 1997; 80: 730-735.
33. Opadijo OG, Omotoso ABO, Akande AA. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians. Afr J Med Sci, 2003; 32: 395-399.
34. Schmieder R, Grube E, Ruddel H, Schlebush W. Microproteinuria as a marker for target organ damage in essential hypertension. Klin Wochenschr, 1990; 68: 256-262.
35. Pontremoli R, Sofia A, Ravera M et al. Prevalence and clinical correlates of MA in essential hypertension. Hypertens, 1997; 30: 1135-1143.
36. Biggazi R, Bianchi S, Nenci R, Baldari G, Campese VM. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria under short intensive therapy. J Hum Hypertens, 1995; 9: 827-833.